Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 16 December 2003
Vol. 2003, Issue 213, p. tw490
[DOI: 10.1126/stke.2132003tw490]

EDITORS' CHOICE

UBIQUITINATION Fateful Dose of Mdm2

The p53 tumor suppressor pathway is frequently inactivated in human cancer. In response to stress, the cellular levels of p53 protein rise, which can lead either to cell growth arrest or apoptosis. In normal cells, p53 levels are kept low through rapid protein turnover. This process is tightly regulated by the E3 ubiquitin ligase Mdm2, but experiments aimed at dissecting the mechanistic details have yielded conflicting results. Li et al. now show that the fate of p53 is determined by the level of Mdm2 activity in the cell. Low levels of Mdm2 promote monoubiquitination and nuclear export of p53, whereas high levels of Mdm2 promote its polyubiquitination and degradation in the nucleus.

M. Li, C. L. Brooks, F. Wu-Baer, D. Chen, R. Baer, W. Gu, Mono- versus polyubiquitination: Differential control of p53 fate by Mdm2. Science 302, 1972-1975 (2003). [Abstract] [Full Text]

Citation: Fateful Dose of Mdm2. Sci. STKE 2003, tw490 (2003).


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882